December 19, 2017
Hikma nets deal with Celltrion for third biosimilar product in the MENA
Hikma Pharmaceuticals has reached a licensing agreement with South Korea-based Celltrion, Inc. and Celltrion Healthcare, Inc (Celltrion) for the first…